2014.02.17. INV-17 ROR gamma Autoimmune Disease Preclinical POC

Written by Adam Parks

INV-17 preclinical findings of its Autoimmune Disease portfolio profiled in BioCentury Week in Review

Read More +

Adam Parks https://apollocreativeco.com
Previous

2014.05.15. INV-17 ROR gamma inhibitor portfolio in preclinical development stage
Next

2014.01.21. Innovimmune INV-17 ROR gamma inhibitor prevents Multiple Sclerosis in mice